225 related articles for article (PubMed ID: 38422019)
1. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.
Katsumura KR; Liu P; Kim JA; Mehta C; Bresnick EH
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2317147121. PubMed ID: 38422019
[TBL] [Abstract][Full Text] [Related]
2. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
[TBL] [Abstract][Full Text] [Related]
3. Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.
Li HS; Jin J; Liang X; Matatall KA; Ma Y; Zhang H; Ullrich SE; King KY; Sun SC; Watowich SS
Eur J Haematol; 2016 Sep; 97(3):261-70. PubMed ID: 26660446
[TBL] [Abstract][Full Text] [Related]
4. A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation.
Moriguchi T; Yamamoto M
Int J Hematol; 2014 Nov; 100(5):417-24. PubMed ID: 24638828
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks.
Jung MM; Shen S; Botten GA; Olender T; Katsumura KR; Johnson KD; Soukup AA; Liu P; Zhang Q; Jensvold ZD; Lewis PW; Beagrie RA; Low JK; Yang L; Mackay JP; Godley LA; Brand M; Xu J; Keles S; Bresnick EH
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36809258
[TBL] [Abstract][Full Text] [Related]
6. Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?
Bresnick EH; Jung MM; Katsumura KR
Blood Adv; 2020 Sep; 4(18):4584-4592. PubMed ID: 32960960
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer.
Soukup AA; Zheng Y; Mehta C; Wu J; Liu P; Cao M; Hofmann I; Zhou Y; Zhang J; Johnson KD; Choi K; Keles S; Bresnick EH
J Clin Invest; 2019 Mar; 129(3):1180-1192. PubMed ID: 30620726
[TBL] [Abstract][Full Text] [Related]
8. Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.
Wu Z; Gao S; Diamond C; Kajigaya S; Chen J; Shi R; Palmer C; Hsu AP; Calvo KR; Hickstein DD; Holland SM; Young NS
Blood Adv; 2020 Jun; 4(12):2656-2670. PubMed ID: 32556286
[TBL] [Abstract][Full Text] [Related]
9. Gata2 noncoding genetic variation as a determinant of hematopoietic stem/progenitor cell mobilization efficiency.
Soukup AA; Bresnick EH
Blood Adv; 2023 Dec; 7(24):7564-7575. PubMed ID: 37871305
[TBL] [Abstract][Full Text] [Related]
10. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
[TBL] [Abstract][Full Text] [Related]
11. Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories.
Johnson KD; Conn DJ; Shishkova E; Katsumura KR; Liu P; Shen S; Ranheim EA; Kraus SG; Wang W; Calvo KR; Hsu AP; Holland SM; Coon JJ; Keles S; Bresnick EH
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32736380
[TBL] [Abstract][Full Text] [Related]
12. Gata2 +9.5 enhancer regulates adult hematopoietic stem cell self-renewal and T-cell development.
You X; Zhou Y; Chang YI; Kong G; Ranheim EA; Johnson KD; Soukup AA; Bresnick EH; Zhang J
Blood Adv; 2022 Feb; 6(4):1095-1099. PubMed ID: 34516632
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function.
Johnson KD; Jung MM; Tran VL; Bresnick EH
Curr Opin Hematol; 2023 Jul; 30(4):117-123. PubMed ID: 37254854
[TBL] [Abstract][Full Text] [Related]
14. GATA2 deficiency elevates interferon regulatory factor-8 to subvert a progenitor cell differentiation program.
Johnson KD; Soukup AA; Bresnick EH
Blood Adv; 2022 Mar; 6(5):1464-1473. PubMed ID: 35008108
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia.
Ping N; Sun A; Song Y; Wang Q; Yin J; Cheng W; Xu Y; Wen L; Yao H; Ma L; Qiu H; Ruan C; Wu D; Chen S
Leukemia; 2017 Jan; 31(1):195-202. PubMed ID: 27389056
[TBL] [Abstract][Full Text] [Related]
16. GATA2 regulates dendritic cell differentiation.
Onodera K; Fujiwara T; Onishi Y; Itoh-Nakadai A; Okitsu Y; Fukuhara N; Ishizawa K; Shimizu R; Yamamoto M; Harigae H
Blood; 2016 Jul; 128(4):508-18. PubMed ID: 27259979
[TBL] [Abstract][Full Text] [Related]
17. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program.
Mehta C; Johnson KD; Gao X; Ong IM; Katsumura KR; McIver SC; Ranheim EA; Bresnick EH
Cell Rep; 2017 Sep; 20(12):2966-2979. PubMed ID: 28930689
[TBL] [Abstract][Full Text] [Related]
18. Mechanism governing a stem cell-generating cis-regulatory element.
Sanalkumar R; Johnson KD; Gao X; Boyer ME; Chang YI; Hewitt KJ; Zhang J; Bresnick EH
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):E1091-100. PubMed ID: 24616499
[TBL] [Abstract][Full Text] [Related]
19. C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor.
Di Genua C; Valletta S; Buono M; Stoilova B; Sweeney C; Rodriguez-Meira A; Grover A; Drissen R; Meng Y; Beveridge R; Aboukhalil Z; Karamitros D; Belderbos ME; Bystrykh L; Thongjuea S; Vyas P; Nerlov C
Cancer Cell; 2020 May; 37(5):690-704.e8. PubMed ID: 32330454
[TBL] [Abstract][Full Text] [Related]
20. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
